Purchases and Sales Made in Q4 2022 in Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB) during Q4 2022. The information is specifically focused on institutions that hold shares of PharmaCyte Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
K2 Principal Fund, L.P.
Toronto, A6 |
BUY
|
- |
121K+ 19.79% |
$289K - $371K
|
732K
$1.15M
|
|
|
Jan 10, 2023
Q4 2022
|
Fny Investment Advisers, LLC
|
BUY
|
- |
31.1KNew |
$74.3K - $95.5K
|
31.1K
$48.8K
|
|
|
Feb 14, 2023
Q4 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
20.7KNew |
$49.5K - $63.6K
|
20.7K
$32.5K
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
17.5KNew |
$41.8K - $53.7K
|
17.5K
$27.5K
|
|
|
Feb 13, 2023
Q4 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
17.2KNew |
$41.2K - $52.9K
|
17.2K
$27K
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
11.3K+ 1.76% |
$27.1K - $34.8K
|
655K
$1.03M
|
|
|
Feb 08, 2023
Q4 2022
|
Iq Eq Fund Management (Ireland) LTD
|
BUY
|
- |
2.03K+ 5.23% |
$4.85K - $6.23K
|
40.8K
$64.1K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
836+ 7.5% |
$2K - $2.57K
|
12K
$18.8K
|
|
|
Feb 14, 2023
Q4 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
400+ 1.61% |
$956 - $1.23K
|
25.2K
$39.6K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
110+ 113.4% |
$263 - $338
|
207
$325
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
44+ 81.48% |
$105 - $135
|
98
$154
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
24+ 77.42% |
$57.4 - $73.7
|
55
$86.4
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 2.17% |
$7.17 - $9.21
|
141
$221
|
|
|
Feb 14, 2023
Q4 2022
|
Clearstead Advisors, LLC
Cleveland, OH |
BUY
|
- |
3New |
$7.17 - $9.21
|
3
$4.71
|
|
|
Feb 14, 2023
Q4 2022
|
New Edge Advisors, LLC
New Orleans, LA |
BUY
|
- |
2New |
$4.78 - $6.14
|
2
$3.14
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2024
Q4 2022
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
SELL
|
- |
-7Closed |
$16.7 - $21.5
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-11- 0.03% |
$26.3 - $33.8
|
37.6K
$59.1K
|
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-53- 35.1% |
$127 - $163
|
98
$154
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-343- 0.2% |
$820 - $1.05K
|
175K
$275K
|
|
|
Feb 02, 2023
Q4 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-1.81K- 2.77% |
$4.33K - $5.56K
|
63.6K
$99.9K
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-10.6K- 22.55% |
$25.3K - $32.5K
|
36.4K
$57.1K
|
|
|
Feb 14, 2023
Q4 2022
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-470K- 82.74% |
$1.12M - $1.44M
|
98K
$154K
|